Stock SOPH SOPHIA GENETICS SA
Add to a list
To use this feature you must be a member
Log inSign up

Ratings SOPHiA GENETICS SA

Equities

SOPH

CH1125843347

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
5.03 USD +1.62% Intraday chart for SOPHiA GENETICS SA +1.41% +6.79%
04-23 Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering MT
04-23 SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The company's enterprise value to sales, at 3.44 times its current sales, is high.
  • The company appears highly valued given the size of its balance sheet.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
SOPHIA GENETICS SA Stock SOPHiA GENETICS SA
+6.79% 328M -
SYNOPSYS INC. Stock Synopsys Inc.
+5.58% 82.93B
B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+3.69% 76.85B
B+
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-14.62% 53.04B
B+
ATLASSIAN CORPORATION Stock Atlassian Corporation
-24.56% 46.55B
B-
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+31.16% 50.15B
D+
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+17.75% 41.41B
D+
SEA LIMITED Stock Sea Limited
+55.21% 35.63B
D+
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-10.24% 24.64B
C+
ROBLOX CORPORATION Stock Roblox Corporation
-21.24% 23.04B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SOPH Stock
  4. Ratings SOPHiA GENETICS SA